The decision framework: a structured approach for breastfeeding mothers Given the complexity of this decision, a structured approach can help mothers and their physicians evaluate whether GLP-1 therapy during breastfeeding is appropriate for their specific situation
[PubMed | ClinicalTrials.gov | DOI] Get Expert Support from FormBlends Managing multiple medications calls for a provider who sees the whole picture
57 : 985990 Krsmanovic LZ, Virmani MA, Stojilkovic SS, Catt KJ
Liraglutide (Saxenda and Victoza) Saxenda and Victoza are brand-name medications for liraglutide, which is the first GLP-1 agonist
For women deciding between options in 2025 and 2026, the decision framework generally looks like this
Each updated page now includes a more complete schema package with offer details, review data, aggregate ratings, shipping information, return-policy fields, and availability signals where relevant